AI Transparency

Version: v1.0
Effective Date: July 23, 2026
Governing entity: DyZen Med LLC

1. Purpose

This summary explains, in plain language, how artificial intelligence and related technologies are used in DyZen Med. It supplements the Terms of Service, Privacy Policy, and Business Associate Agreement. It is not legal advice and is not a certification of regulatory compliance.

2. What DyZen Med does with AI

DyZen Med uses artificial intelligence and related technologies to organize, summarize, analyze, and assist with the interpretation of clinical and medical-legal information. Depending on the feature used, these capabilities may:

Not every feature performs every function. Features are presented as physician-assist tools.

3. What DyZen Med does not do

Generated content must be reviewed and approved by the qualified healthcare professional responsible for its use. A report is not final until the authenticated physician attestation / Final Version process is completed where that workflow is used.

4. Human review and authorship

DyZen-generated analysis documents are assistive and attributed to DyZen Med / Zentelligence where required. Physician-owned drafts and physician-attested final reports remain the professional responsibility of the physician or practice. DyZen Med does not claim authorship or approval of a physician’s final opinion.

5. External references and terminology

Opinion Intelligence may consult external terminology (including UMLS) and literature, trial, or labeling sources. Terminology matches are not clinical evidence. External references are advisory only. Details: Clinical Evidence Sources and Attribution.

6. Support assistants

In-product support assistants (including Zena) are automated helpers for product and account questions. They are not covered PHI channels, do not provide medical or legal advice, and may escalate to human support. Response times are not guaranteed unless a separate enforceable service commitment applies.

7. Contact

info@dyzenmed.com

Draft prepared for subsequent counsel review. Unresolved policy choices are tracked in the counsel-review packet.